JCI Insight is an Gold Open Access journal that has a 2022 Impact Factor of 8.0. The Journal publishes well-executed, high-quality studies that provide meaningful contributions to the understanding of the biology and/or treatment of disease, with an emphasis on clinically relevant basic and translational research. Submissions are welcome from all biomedical specialties, including autoimmunity, gastroenterology, immunology, metabolism, nephrology, neuroscience, oncology, pulmonology, vascular biology, and many others.
JCI Insight is self-published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists established in 1908. JCI Insight serves to fulfill the ASCI’s objective to advance medical science through the publication of clinically relevant research reports.
JCI Insight is headed by Editor in Chief Dr. Kathleen L. Collins, and manuscripts are adjudicated by our team of academic and professional editors. Information about the editors can be found here. In addition, the editors may seek the advice of members of our consulting editorial board.